ICOS anticorps (Cy7,PE)

N° du produit ABIN476815

Cet anticorps Souris Monoclonal détecte spécifiquement ICOS dans FACS. Il présente une réactivité envers Humain.

Aperçu rapide pour ICOS anticorps (Cy7,PE) (ABIN476815)

Antigène: ICOS (Inducible T-Cell Co-Stimulator (ICOS))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ICOS est conjugé à/à la Cy7,PE

Application: Flow Cytometry (FACS)

Clone: ISA-3

Détail du produit anti-ICOS anticorps (Cy7,PE)

Purification: Affinity purified

Immunogène: Human ICOS

Isotype: IgG1 kappa

Information d'application

Indications d'application: Approved: Flo

Usage: This ISA-3 antibody has been pre-titrated and tested by flow cytometric analysis of stimulated normal human peripheral blood cells. This can be used at 5 μL (0.125 μg)/per test. A test is defined as the amount (ug)/test of antibody that will stain a cell sample in a final volume of 100 μL. Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Aqueous buffer, 0.09 % sodium azide, contains stabilizer if necessary

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Do not freeze. Product is photosensitive and should be protected from light.

Stock: 4 °C

Stockage commentaire: Store at 4°C. Do not freeze. Protect from light.

Détails sur ICOS

Antigène: ICOS (Inducible T-Cell Co-Stimulator (ICOS))

Autre désignation: ICOS / CD278

Sujet: Name/Gene ID: ICOS

Synonyms: ICOS, AILIM, CD278, CVID1, Inducible costimulator, Inducible T-cell co-stimulator, CD278 antigen, Inducible T-cell costimulator

ID gène: 29851

UniProt: Q9Y6W8

Pathways: Cancer Immune Checkpoints